Challenging assumptions about in vivo CAR-T cell therapy and is ‘off-the-shelf’ the only future for cell therapies?

An exploration from Dr. Borriello about why the growing excitement around in vivo CAR-T approaches may be overlooking key scientific and safety realities — and how Alloplex’s immune cell training platform takes a fundamentally different path